---
figid: PMC10507286__ibj-27-199-g001
pmcid: PMC10507286
image_filename: ibj-27-199-g001.jpg
figure_link: /pmc/articles/PMC10507286/figure/F1/
number: Fig.1
figure_title: ''
caption: Isorhamnetin effects at different concentrations on the HSCs-T6 viability.
  The MTT assay data reveal the viability of the cells after 24 h. The results are
  presented with mean Â± SEM. Analysis was done by Tukey test, one-way ANOVA, (**p
  < 0.01, ***p < 0.001).
article_title: Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived
  Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling
  Pathway.
citation: Mojtaba Rashidi, et al. Iran Biomed J. 2023 Jul;27(4):199-204.
year: '2023'

doi: 10.61186/ibj.3948
journal_title: Iranian Biomedical Journal
journal_nlm_ta: Iran Biomed J
publisher_name: Pasteur Institute of Iran

keywords:
- Hepatitis
- Liver injuries
- PI3K-AKT

---
